Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126006121 | 12600612 | 1 | I | 20160131 | 20160718 | 20160727 | 20160727 | EXP | FR-FRESENIUS KABI-FK201604764 | FRESENIUS KABI | 54.61 | YR | M | Y | 0.00000 | 20160727 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126006121 | 12600612 | 1 | PS | VOLUVEN | HYDROXYETHYL STARCH 130/0.4 | 1 | Intravenous drip | U | UNK | 70012 | 1 | DF | SOLUTION FOR INFUSION | QD | |||||
| 126006121 | 12600612 | 2 | SS | VISIPAQUE | IODIXANOL | 1 | Unknown | 0 | |||||||||||
| 126006121 | 12600612 | 3 | SS | ARIXTRA | FONDAPARINUX SODIUM | 1 | Intravenous (not otherwise specified) | 0 | 1 | DF | QD | ||||||||
| 126006121 | 12600612 | 4 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 0 | ||||||||||||
| 126006121 | 12600612 | 5 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | ||||||||||||
| 126006121 | 12600612 | 6 | C | BISOPROLOL | BISOPROLOL | 1 | 0 | ||||||||||||
| 126006121 | 12600612 | 7 | C | METFORMINE | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126006121 | 12600612 | 8 | C | ATORVASTATINE | ATORVASTATIN | 1 | 0 | ||||||||||||
| 126006121 | 12600612 | 9 | C | NATISPRAY | NITROGLYCERIN | 1 | 0 | ||||||||||||
| 126006121 | 12600612 | 10 | C | NICOPASS | NICOTINE | 1 | 0 | ||||||||||||
| 126006121 | 12600612 | 11 | C | ASPEGIC | ASPIRIN DL-LYSINE | 1 | 0 | ||||||||||||
| 126006121 | 12600612 | 12 | C | BRILIQUE | TICAGRELOR | 1 | 0 | ||||||||||||
| 126006121 | 12600612 | 13 | C | TILDIEM | DILTIAZEM HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126006121 | 12600612 | 14 | C | RISORDAN | ISOSORBIDE DINITRATE | 1 | 0 | ||||||||||||
| 126006121 | 12600612 | 15 | C | ATROPINE. | ATROPINE | 1 | 0 | ||||||||||||
| 126006121 | 12600612 | 16 | C | AGRASTA | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126006121 | 12600612 | 1 | Product used for unknown indication |
| 126006121 | 12600612 | 2 | Product used for unknown indication |
| 126006121 | 12600612 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126006121 | 12600612 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126006121 | 12600612 | Erythema | |
| 126006121 | 12600612 | Pruritus | |
| 126006121 | 12600612 | Toxic skin eruption |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126006121 | 12600612 | 1 | 20160126 | 0 | ||
| 126006121 | 12600612 | 2 | 20160126 | 0 | ||
| 126006121 | 12600612 | 3 | 20160126 | 0 |